You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The FDA established the platform to allow scientists to test their NGS assays and to advance the regulatory science for assessing genomic tests and software.
The companies have signed an agreement to integrate Qiagen's variant interpretation solution with DNAnexus' cloud-based platform.
The companies will provide access to IrysSolve, BioNano's whole-genome analysis algorithms and pipeline, on DNAnexus' cloud platform.
The so-called precisionFDA system will provide a forum for sharing data and software as well as deriving standards to enable NGS-based testing
DNANexus will handle data from CareDx's cell-free transplant assay as well as support its ongoing research and development activities.
Using funds from the California precision medicine initiative, the group will use its bioinformatics expertise to match patients to treatments in pediatric clinical trials.
The initiative aims to integrate clinical, genomic, environmental, and other data from patients to help determine disease mechanisms and develop precise therapies.
DNAnexus' platform will support data analysis and sharing for the third phase of the Encyclopedia of DNA Elements project.
The so-called HgV platform offers tools for analyzing high-throughput whole genome sequence data for precision medicine research and clinical applications
The 3000 Rice Genomes Project will use DNANexus' platform in effort to improve nutrition, climate tolerance, and disease resistance in rice.
Researchers have developed a robotic lab assistant, the Verge reports.
CBC News reports Canada's Supreme Court is to rule on the constitutionality of the country's genetic non-discrimination law today.
The Associated Press reports the World Health Organization is sending experts to China to investigate the animal source of SARS-CoV-2.
In Science this week: atlas of affected cell populations in idiopathic pulmonary fibrosis, and more.